SAGIMET BIOSCIENCES
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.
SAGIMET BIOSCIENCES
Social Links:
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2007-03-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.sagimet.com
Total Employee:
11+
Status:
Active
Contact:
+1 650.561.8600
Email Addresses:
[email protected]
Total Funding:
293.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Adverum Biotechnologies
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Animal Bioscience
Animal Bioscience is a pet platform.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
BridGene Biosciences
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
D2G Oncology
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Locus Biosciences
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
New Age Meats
New Age Meats is a biotechnology company that develops healthy cultivated meat grown from animal cells instead of animal slaughter.
NexImmune
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Oncoheroes Biosciences
Oncoheroes Biosciences is a biotech company.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reservoir Neuroscience
Reservoir Neuroscience is a biopharma company that develops novel therapeutics.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Scopus BioPharma
Scopus BioPharma is a biotechnology company that focused on developing therapeutics targeting serious diseases.
Siolta Therapeutics
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Somru Bioscience
Somru Bioscience is an emerging biotechnology company dedicated to developing breakthrough antibody technology for research.
SynerGene Therapeutics
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.
Trait Biosciences
Trait Biosciences is a cannabis biotechnology company harnessing research scientists.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Invus
Invus investment in Venture Round - Sagimet Biosciences
Altium Capital
Altium Capital investment in Venture Round - Sagimet Biosciences
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Sagimet Biosciences
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Sagimet Biosciences
Ascletis
Ascletis investment in Venture Round - Sagimet Biosciences
Huimei Capital
Huimei Capital investment in Venture Round - Sagimet Biosciences
PFM Health Sciences
PFM Health Sciences investment in Venture Round - Sagimet Biosciences
Kleiner Perkins
Kleiner Perkins investment in Venture Round - Sagimet Biosciences
New Enterprise Associates
New Enterprise Associates investment in Series E - Sagimet Biosciences
Qianhai Ark
Qianhai Ark investment in Series E - Sagimet Biosciences
Official Site Inspections
http://www.sagimet.com
- Host name: ec2-34-211-132-55.us-west-2.compute.amazonaws.com
- IP address: 34.211.132.55
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Sagimet Biosciences"
Senior Management - Sagimet Biosciences
Dr. O’Farrell has led Sagimet’s R&D team as senior vice president of research and development since 2019 and previously served as Sagimet’s senior director of translational sciences from …See details»
Board of Directors FASN Products Company - Sagimet Biosciences
Dr. Kemble joined Sagimet Biosciences in August 2011 as its chief scientific officer and served as chief executive officer from October 2015 until October 2022, when he transitioned to the role …See details»
Sagimet Biosciences - Crunchbase Company Profile
Sagimet Biosciences has shown positive growth indicators. The company is in a good position to deliver on its growth plans, as evidenced by the imminent Phase 3 trial of its therapeutic, Denifanstat. Additionally, the company has maintained …See details»
Investor FAQs - Sagimet Biosciences Inc
Jul 14, 2023 Sagimet’s transfer agent is American Stock Transfer & Trust Company, LLC (AST). You can find more information about how to contact AST at: American Stock Transfer & Trust …See details»
Sagimet Biosciences Announces Leadership Changes - Yahoo …
SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics …See details»
Investors & Media | Sagimet Biosciences Inc
Nov 7, 2024 Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates. Read More . 11/7/2024 Sagimet Biosciences to Participate in the UBS …See details»
SEC Filings - Sagimet Biosciences Inc
Nov 14, 2024 The Investor Relations website contains information about Sagimet Biosciences Inc's business for stockholders, potential investors, and financial analysts.See details»
Sagimet Biosciences Inc. (SGMT) - Yahoo Finance
Find the latest Sagimet Biosciences Inc. (SGMT) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Sagimet Biosciences Inc. (SGMT) - Yahoo Finance Canada
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from …See details»
Senior Management - Sagimet Biosciences
Marie O’Farrell (PhD) is Vice-President of Research and Development at Sagimet and was the Senior Director of Translational Sciences from 2013 to 2016. Dr. O’Farrell started her career in …See details»
Sagimet: More Than Just A MASH Drug Development Biotech
Nov 14, 2024 According to the 10-Q SEC Filing, Sagimet Biosciences had cash, cash equivalents and marketable securities of $188.5 million as of June 30th of 2024. The reason …See details»
Sagimet Biosciences Inc. (SGMT) - Stock Analysis
2 days ago Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that …See details»
About | Inhibitor Of FASN - Sagimet Biosciences
Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in …See details»
News Releases - Sagimet Biosciences Inc
Sep 12, 2024 Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program …See details»
Sagimet Biosciences' Denifanstat Imminent Phase 3: A Promising ...
Apr 26, 2024 Sagimet Biosciences Inc. (SGMT) is a clinical-stage biopharmaceutical firm headquartered in San Mateo, California. It was founded in 2006 under 3-V Biosciences, Inc. …See details»
Sagimet Biosciences to Participate in the Piper Sandler 36th …
5 days ago Sagimet’s lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction associated …See details»
Sagimet Biosciences to Participate in the Piper Sandler 36th …
5 days ago SAN MATEO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel …See details»
Sagimet Biosciences Inc. (SGMT) - Yahoo Finance
Interactive Chart for Sagimet Biosciences Inc. (SGMT), analyze all the data with a huge range of indicators.See details»
Sagimet Biosciences Announces Positive Topline Results from …
Jan 22, 2024 Sagimet’s lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of NASH, for which there are no treatments …See details»